Wells Fargo & Company First Wave Bio Pharma, Inc. Transaction History

Wells Fargo & Company

  • $434 Billion
  • Q3 2024

Shares

2 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2022

Feb 13, 2023
BUY
$0.46 - $1.15 $13 - $33
29 Added 14.8%
225 $0
Q3 2022

Nov 14, 2022
BUY
$1.3 - $7.65 $254 - $1,499
196 New
196 $0

Others Institutions Holding FWBI

# of Institutions
1
Shares Held
0
Call Options Held
0
Put Options Held
0
View Full List

About First Wave BioPharma, Inc.

FWBI Quotes by TradingView
  • Ticker FWBI
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,562,010
  • Market Cap $2.54M
  • Description
  • First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. Its product candidates include niclosamide, an oral small molecule with anti-viral and anti-inflammatory properties; and the biologic ...
More about FWBI
Track This Portfolio

Track Wells Fargo & Company Portfolio

Follow Wells Fargo & Company and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email